[HTML][HTML] Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease

N Kobayashi, S Shinagawa, H Niimura, H Kida… - Scientific reports, 2020 - nature.com
Early diagnosis of dementia including Alzheimer's disease (AD) is an urgent medical and
welfare issue. However, to date, no simple biometrics have been available. We reported that …

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease.

N Kobayashi, S Shinagawa, H Niimura… - Scientific …, 2020 - search.ebscohost.com
Early diagnosis of dementia including Alzheimer's disease (AD) is an urgent medical and
welfare issue. However, to date, no simple biometrics have been available. We reported that …

[HTML][HTML] Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease

N Kobayashi, S Shinagawa, H Niimura, H Kida… - Scientific …, 2020 - ncbi.nlm.nih.gov
Early diagnosis of dementia including Alzheimer's disease (AD) is an urgent medical and
welfare issue. However, to date, no simple biometrics have been available. We reported that …

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease

N Kobayashi, S Shinagawa, H Niimura… - Scientific …, 2020 - pubmed.ncbi.nlm.nih.gov
Early diagnosis of dementia including Alzheimer's disease (AD) is an urgent medical and
welfare issue. However, to date, no simple biometrics have been available. We reported that …

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease

N Kobayashi, S Shinagawa, H Niimura… - Scientific …, 2020 - keio.elsevierpure.com
抄録 Early diagnosis of dementia including Alzheimer's disease (AD) is an urgent medical
and welfare issue. However, to date, no simple biometrics have been available. We reported …

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease.

N Kobayashi, S Shinagawa, H Niimura, H Kida… - Scientific …, 2020 - europepmc.org
Early diagnosis of dementia including Alzheimer's disease (AD) is an urgent medical and
welfare issue. However, to date, no simple biometrics have been available. We reported that …

[PDF][PDF] increased blood COASY DnA methylation levels a potential biomarker for early pathology of Alzheimer's disease

K Kondo - Scientific RepoRtS, 2020 - researchgate.net
Materials and methods Subjects. Individuals in the present study were independent of those
in our previous study 12, 13. Individuals with aMCI, AD, and VaD were enrolled from the …

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease

N Kobayashi, S Shinagawa, H Niimura… - Scientific …, 2020 - ui.adsabs.harvard.edu
Early diagnosis of dementia including Alzheimer's disease (AD) is an urgent medical and
welfare issue. However, to date, no simple biometrics have been available. We reported that …

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease

N Kobayashi, S Shinagawa, H Niimura, H Kida… - Scientific Reports, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Early diagnosis of dementia including
Alzheimer's disease (AD) is an urgent medical and welfare issue. However, to date, no …

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease

N Kobayashi, S Shinagawa, H Niimura… - Scientific …, 2020 - keio.elsevierpure.com
Early diagnosis of dementia including Alzheimer's disease (AD) is an urgent medical and
welfare issue. However, to date, no simple biometrics have been available. We reported that …